Literature DB >> 11593319

Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism.

W J Savage1, J J Bleesing, D Douek, M R Brown, G M Linton, H L Malech, M E Horwitz.   

Abstract

The effect of mixed chimerism on the pace of post-transplant immune reconstitution is unknown. Using flow cytometry, recall and neo-antigen vaccine responses, and T cell receptor recombination excision circle (TREC) quantification, we evaluated phenotypic and functional characteristics of T and B cells in nine patients following non-myeloablative, HLA-identical peripheral blood stem cell transplantation for chronic granulomatous disease. Engraftment of T cell, B cell, and myeloid lineages proceeded at similar paces within each patient, but engraftment kinetics segregated patients into two groups: adults, who became full donor T cell chimeras before 6 months (rapid engrafters) and children, who became full donor T cell chimeras after 6 months or not at all (slow engrafters). Quantitative B cell recovery was achieved by 6 weeks after transplantation in children, but was delayed until 1 year in adults. Early quantitative B cell recovery was not accompanied by an early humoral immune response to tetanus toxoid (TT). Emergence of TT-specific T cell responses coincided with naive T cell reconstitution, as measured by CD4/CD45RA T cell recovery and TREC quantification. These data suggest that immune reconstitution occurs faster in pediatric patients who have prolonged mixed hematopoietic chimerism compared to adults, who have rapid donor stem cell engraftment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593319     DOI: 10.1038/sj.bmt.1703176

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

Review 1.  Optimizing drug therapy in pediatric SCT: focus on pharmacokinetics.

Authors:  J S McCune; P Jacobson; A Wiseman; O Militano
Journal:  Bone Marrow Transplant       Date:  2014-10-27       Impact factor: 5.483

2.  The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation.

Authors:  Roberta Fedele; Massimo Martino; Cristina Garreffa; Giuseppe Messina; Giuseppe Console; Domenica Princi; Antonella Dattola; Tiziana Moscato; Elisabetta Massara; Elisa Spiniello; Giuseppe Irrera; Pasquale Iacopino
Journal:  Blood Transfus       Date:  2012-01-24       Impact factor: 3.443

3.  No recovery of T-cell receptor excision circles (TRECs) after non-myeloablative allogeneic hematopoietic stem cell transplantation is correlated with the onset of GvHD.

Authors:  Grzegorz K Przybylski; Karl-A Kreuzer; Wolfgang Siegert; Christian A Schmidt
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

Review 4.  The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases.

Authors:  Michael Maris; Rainer Storb
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 5.  Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  George E Georges; Rainer Storb
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

Review 6.  Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I.

Authors:  Jeannine S McCune; Meagan J Bemer
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

7.  Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation.

Authors:  Nancy M Hardy; Frances Hakim; Seth M Steinberg; Michael Krumlauf; Romana Cvitkovic; Rebecca Babb; Jeanne Odom; Daniel H Fowler; Ronald E Gress; Michael R Bishop
Journal:  Biol Blood Marrow Transplant       Date:  2007-07-16       Impact factor: 5.742

Review 8.  T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome.

Authors:  Ahmed Gaballa; Mikael Sundin; Arwen Stikvoort; Muhamed Abumaree; Mehmet Uzunel; Darius Sairafi; Michael Uhlin
Journal:  Int J Mol Sci       Date:  2016-10-11       Impact factor: 5.923

Review 9.  Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions.

Authors:  Asaf Yanir; Ansgar Schulz; Anita Lawitschka; Stefan Nierkens; Matthias Eyrich
Journal:  Front Pediatr       Date:  2022-01-11       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.